2× LLY: LLYX vs ELIL
YTDYear to date
ELIL wins+5.4 pts
Fee
ELIL winslower fee
Yield
ELIL wins+5.9 pts
LLY per $1,000
Levelboth 2x daily
AUM
LLYX1.8× more
3–0ELIL wins
End-of-day Nov 4, 2026 · both reset daily · AUM not scored
| # | Gives you | |||||||
|---|---|---|---|---|---|---|---|---|
| 4Heaviest basketsLLY is the biggest slice; over $1B first390 funds hold it in their top 10All 250 → | ||||||||
| 1 | IHE | iShares U.S. Pharmaceuticals ETFReadDesk | 26.9% LLY | $269 | +26.9% | 1.3% | 0.37% | $1.6B |
| 2 | PPH | VanEck Pharmaceutical ETFReadDesk | 23.2% LLY | $232 | +17.0% | 1.8% | 0.36% | $1.1B |
| 3 | MEDI | Harbor Health Care ETF (MEDI)ReadDesk | 22.2% LLY | $222 | +11.5% | 0.2% | 0.80% | $45.4M |
| 4 | MEDX | Horizon Kinetics Medical ETFReadDesk | 21.0% LLY | $210 | +13.9% | 1.1% | 0.85% | $17.8M |
| 5 | TRUH | VanEck Healthcare TruSector ETFReadDesk | 16.9% LLY | $169 | — | 0.7% | 0.10% | $642K |
| 6 | XLV | State Street Health Care Select Sector SPDR ETFReadDesk | 16.5% LLY | $165 | +20.4% | 1.4% | 0.08% | $49.1B |
| 1Double it2x LLY’s move each day2 funds · $62MAll 2 → | ||||||||
| 7 | LLYX | Daily Target 2X Long LLY ETFReadDesk | 2x daily | $2,000 | +37.7% | 2.0% | 1.49% | $40.3M |
| 8 | ELIL | Direxion Daily LLY Bull 2X ETFReadDesk | 2x daily | $2,000 | +43.1% | 7.9% | 1.31% | $22.1M |
| 7Geared basketsLeveraged index funds with LLY inside6 fundsAll 6 → | ||||||||
| 9 | SPXL | Direxion Daily S&P 500 Bull 3X SharesReadDesk | 3x daily | — | +22.5% | 0.5% | 0.95% | $6.5B |
| 10 | SPUU | Direxion Daily S&P 500 Bull 2X ETFReadDesk | 2x daily | — | +17.8% | 1.3% | 0.66% | $275M |
| 11 | CURE | Direxion Daily Healthcare Bull 3X ETFReadDesk | 3x daily | — | +49.8% | 0.8% | 0.94% | $200M |
| 12 | RXL | ProShares Ultra Health CareReadDesk | 2x daily | — | +35.0% | 0.9% | 1.08% | $112M |
| 13 | URSP | ProShares - Ultra S&P 500 Equal WeightReadDesk | 2x daily | — | +26.3% | 1.2% | 1.34% | $41.9M |
| 14 | PILL | Direxion Daily Pharmaceutical & Medical Bull 3X ETFReadDesk | 3x daily | — | +22.7% | 0.4% | 1.22% | $13.8M |
51%in Low-Cost Core funds